Screener
Acadia Pharmaceuticals ACAD Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's price / sales?
- Acadia Pharmaceuticals (ACAD) reported price / sales of 3.8× in Q2 2026.
- How has Acadia Pharmaceuticals's price / sales changed year-over-year?
- Acadia Pharmaceuticals's price / sales increased by 3.4% year-over-year, from 3.7× to 3.8×.
- What is the long-term trend for Acadia Pharmaceuticals's price / sales?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's price / sales has grown at a -26.3% compound annual growth rate (CAGR), from 19.5× to 4.2×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Acadia Pharmaceuticals's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude